.svg){kind=small}
May-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In May 2026, Oil concentrated 90.78% share with year-over-year decline of 14.71% and month-over-month decline of 7.49%, while Vapor Pens held 6.68% share with a 40.34% year-over-year decline but a 26.05% month-over-month increase; Edible reached 2.04% share with 47.76% year-over-year growth and 5.92% month-over-month growth, as Capsules slipped to 0.50% share with a 67.07% year-over-year drop and a 1.45% month-over-month uptick. Average price fell 4.30% year over year to $42.09, and Oil’s price at $42.36 sat near the brand average, indicating the mix shift is being driven more by volume contraction in Oil and tactical month-over-month recovery in Vapor Pens than by broad pricing moves; this pattern implies category concentration risk centered in Oil even as small-format innovations in Edible and Vapor Pens begin to offset declines at the margin.
The category skew toward Oil amplifies exposure to its 14.71% year-over-year and 7.49% month-over-month contractions, while the 26.05% month-over-month rebound in Vapor Pens and 47.76% year-over-year growth in Edible suggest early diversification vectors that are still too small at 6.68% and 2.04% share to materially counterbalance downside. With Alberta Oil placement at rank 1 alongside a brand-level sales decline of 17.03% year over year and a 46.06% drop versus 24 months, the positioning signal is market-leadership in a shrinking core and under-scaled adjacency in Vapor Pens; this implies priority on defending Oil velocity in Alberta while accelerating share capture in Vapor Pens and Edible to dilute concentration risk.
Competitive Landscape
MediPharm Labs sits at #3 in ON Oil in May 2026, unchanged year over year at #3 and steady versus three months ago at #3, while its historical peak of #2 in December 2024 sets a higher-water mark that contrasts with no rank gain over the past 12 months; meanwhile, Mod climbed from #2 to #1 with a 65.8% year-over-year sales increase as Redecan slipped from #1 to #2 amid a 32.6% year-over-year sales decline, and NightNight held at #4 with a 1.4% year-over-year sales dip while ufeelu moved from #6 to #5 with a 9.9% year-over-year sales increase; the pattern implies MediPharm Labs is holding share position but ceding momentum to a faster-rising leader and a narrowing #5 challenger.
Notable Products
CBN/CBD 1:2 Relax Formula Oil (30ml) posted the steepest decline in May 2026, dropping 27.2% MoM to rank 3 while CBD 50 Plus Olive Formula Oil (30ml) fell 19.9% to rank 5. At the top, THC 30 Regular Formula Oil (30ml) in rank 1 grew 3.4% MoM, and CBN:THC 1:2 Nighttime Formula Oil (30ml) in rank 2 slipped 6.6%. With eight of the top ten SKUs in Oil and only one Edible and one Vapor Pen, the portfolio is concentrated in tinctures even as mixed-cannabinoid oils retreat, implying a tilt toward high-THC flagship retention rather than breadth across alternative formats.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
